Abstract

There is a need to increase the vaccine completion rates in women who have already received human papillomavirus (HPV) vaccines. With vaccines requiring multiple doses, designing a vaccination control program and increasing the proportion of women who complete vaccination are critical and remain as huge challenges. Currently, there are no published reports on the differences in the background characteristics between postpartum women who are vaccinated or unvaccinated against HPV. This study aimed to determine the vaccination rates of the second and third doses of HPV vaccination utilizing an achievable HPV vaccination program in postpartum women. In this retrospective study, 243 postpartum women attending Chiayi Chang Gung Memorial Hospital between March and September 2014 were enrolled. These women were classified into two groups: one group received the HPV vaccine under a practical, controlled postpartum HPV vaccination program, and the other group did not. The rates for the second and third rounds of HPV vaccination in postpartum women were calculated. The differences in the background characteristics between the two groups were determined using the Student’s t test, chi-square test or Fisher’s exact test, and the multiple logistic models, as appropriate. Under the controlled postpartum HPV vaccination program, the completion rate for the three doses of postpartum HPV vaccination was 97.2%. Significant differences were observed according to maternal age, gender of the newborn, and postpartum Pap smear results between the two groups in our study. In conclusion, the controlled postpartum HPV vaccination program is a reasonable method for achieving an excellent completion rate for the three doses of postpartum HPV vaccination and may be a good model for any multiple-dose vaccination protocol.

Highlights

  • Cervical cancer in women is the greatest disease burden caused by the human papillomavirus (HPV) infection [1]

  • The postpartum HPV vaccination program (Figure 1) in our hospital was used for the strict monitoring and follow-up of postpartum HPV vaccination cases

  • This study found that age, gender of the newborn, and postpartum Pap smear results were factors determining postpartum HPV vaccination in postpartum women

Read more

Summary

Introduction

Cervical cancer in women is the greatest disease burden caused by the human papillomavirus (HPV) infection [1]. Associations between pregnancy and HPV infection and the trend of increasing cervical cancer risk with greater number of live births are controversial [3,4,5]. Cervical ectropion in women of childbearing age [6, 7], thinning of the cervical epithelium during pregnancy, and injuries to the cervix during vaginal delivery may increase the risk of HPV infection in postpartum women [8]. Women with multiple vaginal deliveries and those of young age at their first full-term delivery have a higher risk of cervical cancer [9]. HPV vaccination is still advantageous for postpartum women. The Taiwan Society of Perinatology and the Taiwan Maternal Fetal Medicine Society promoted postpartum HPV vaccination in 2013 and 2014, respectively

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call